Physician profile
Sukhdeep Singh
NPI 1316328834
$1,922.45
in general payments reported to CMS, 2019-2025
11 companies · $81.39 in 2025
The $81.39 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,521 · 2020: $103 · 2021: $172 · 2022: $45.95 · 2025: $81.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,249.22 | 2019 | |
| Abbvie INC. | $362.54 | 2019-2022 | |
| Coloplast Corp | $81.39 | 2025 | |
| Myovant Sciences INC. | $56.45 | 2021 | |
| Exeltis, USA INC. | $56.25 | 2020-2022 | |
| Hologic Sales and Service, LLC | $33.97 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $23.40 | 2019-2021 | |
| Agile Therapeutics, INC. | $15.00 | 2021 | |
| Organon LLC | $14.98 | 2021 | |
| Evofem Biosciences, INC. | $14.81 | 2021 | |
| Horizon Therapeutics Plc | $14.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sukhdeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.